These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25950000)

  • 61. Identification of Novel Tau-Tubulin Kinase 2 Inhibitors Using Computational Approaches.
    Ahamad S; Hema K; Gupta D
    ACS Omega; 2023 Apr; 8(14):13026-13037. PubMed ID: 37065061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor.
    Kiefer SE; Chang CJ; Kimura SR; Gao M; Xie D; Zhang Y; Zhang G; Gill MB; Mastalerz H; Thompson LA; Cacace AM; Sheriff S
    Acta Crystallogr F Struct Biol Commun; 2014 Feb; 70(Pt 2):173-81. PubMed ID: 24637750
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Dephosphorylation of cytoskeletal proteins: phosphorylation and dephosphorylation of microtubule proteins].
    Yamamoto H; Miyamoto E
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1004-12. PubMed ID: 9655957
    [No Abstract]   [Full Text] [Related]  

  • 64. Human TTBK1, TTBK2 and MARK1 kinase toxicity in
    Fernius J; Starkenberg A; Pokrzywa M; Thor S
    Biol Open; 2017 Jul; 6(7):1013-1023. PubMed ID: 28711868
    [TBL] [Abstract][Full Text] [Related]  

  • 65.
    Muñoz-Estrada J; Nguyen AV; Goetz SC
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes.
    Roth A; Gihring A; Bischof J; Pan L; Oswald F; Knippschild U
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using MTBindingSim as a tool for experimental planning and interpretation.
    Philip JT; Duan AR; Alberico EO; Goodson HV
    Methods Cell Biol; 2013; 115():375-84. PubMed ID: 23973084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The structural, functional, and dynamic effect of Tau tubulin kinase1 upon a mutation: A neuro-degenerative hotspot.
    Ahamad S; Hema K; Kumar V; Gupta D
    J Cell Biochem; 2021 Nov; 122(11):1653-1664. PubMed ID: 34297427
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SILAC kinase screen identifies potential MASTL substrates.
    Marzec KA; Rogers S; McCloy R; Parker BL; James DE; Watkins DN; Burgess A
    Sci Rep; 2022 Jun; 12(1):10568. PubMed ID: 35732702
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TTBK2 kinase: linking primary cilia and cerebellar ataxias.
    Jackson PK
    Cell; 2012 Nov; 151(4):697-699. PubMed ID: 23141531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma.
    Hedna R; Kovacic H; Pagano A; Peyrot V; Robin M; Devred F; Breuzard G
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358803
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.
    Chew J; Gendron TF; Prudencio M; Sasaguri H; Zhang YJ; Castanedes-Casey M; Lee CW; Jansen-West K; Kurti A; Murray ME; Bieniek KF; Bauer PO; Whitelaw EC; Rousseau L; Stankowski JN; Stetler C; Daughrity LM; Perkerson EA; Desaro P; Johnston A; Overstreet K; Edbauer D; Rademakers R; Boylan KB; Dickson DW; Fryer JD; Petrucelli L
    Science; 2015 Jun; 348(6239):1151-4. PubMed ID: 25977373
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Centrosomes. Regulated assembly of a supramolecular centrosome scaffold in vitro.
    Woodruff JB; Wueseke O; Viscardi V; Mahamid J; Ochoa SD; Bunkenborg J; Widlund PO; Pozniakovsky A; Zanin E; Bahmanyar S; Zinke A; Hong SH; Decker M; Baumeister W; Andersen JS; Oegema K; Hyman AA
    Science; 2015 May; 348(6236):808-12. PubMed ID: 25977552
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation.
    Watanabe T; Kakeno M; Matsui T; Sugiyama I; Arimura N; Matsuzawa K; Shirahige A; Ishidate F; Nishioka T; Taya S; Hoshino M; Kaibuchi K
    J Cell Biol; 2015 Aug; 210(5):737-51. PubMed ID: 26323690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43.
    Caccamo A; Shaw DM; Guarino F; Messina A; Walker AW; Oddo S
    Hum Mol Genet; 2015 Aug; 24(16):4625-35. PubMed ID: 26002100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The function of RNA-binding proteins at the synapse: implications for neurodegeneration.
    Sephton CF; Yu G
    Cell Mol Life Sci; 2015 Oct; 72(19):3621-35. PubMed ID: 26047658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alterations in the blood-spinal cord barrier in TDP-43 conditional knockout mice.
    Sasaki S; Iguchi Y; Katsuno M; Sobue G
    Neurosci Lett; 2015 Jun; 598():1-5. PubMed ID: 25957558
    [TBL] [Abstract][Full Text] [Related]  

  • 78. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits.
    Koppers M; Blokhuis AM; Westeneng HJ; Terpstra ML; Zundel CA; Vieira de Sá R; Schellevis RD; Waite AJ; Blake DJ; Veldink JH; van den Berg LH; Pasterkamp RJ
    Ann Neurol; 2015 Sep; 78(3):426-38. PubMed ID: 26044557
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hyperproduction of IL-6 caused by aberrant TDP-43 overexpression in high-fat diet-induced obese mice.
    Lee S; Lee TA; Song SJ; Park T; Park B
    FEBS Lett; 2015 Jul; 589(15):1825-31. PubMed ID: 26037142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 4-Hydroxynonenal induces persistent insolubilization of TDP-43 and alters its intracellular localization.
    Kabuta C; Kono K; Wada K; Kabuta T
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):82-7. PubMed ID: 25998392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.